Hope and uncertainty as India and US strike long-delayed trade deal

US President Donald Trump announced a rollback of reciprocal tariffs on India from 50% to 18%, a move industry participants say could relieve pressure on the rupee, equities and rates after last year’s sharp tariffs and resulting export declines in textiles, seafood and jewellery. The announcement — which follows India’s recent large EU free-trade deal — is being hailed as a directional win for supply‑chain reconfiguration and US‑India ties, but key elements remain unspecified (products covered, timelines, enforceability), and claims of vastly higher US-bound purchases (>$500bn) contrast with current bilateral US imports of under $50bn.

Analysis

Market structure: If tariff normalization to ~18% is formalized, clear winners are Indian export-oriented sectors (textiles, apparel, gems & jewellery) and broader India equity/corporate bond markets as political risk premium falls; expect a 6–18% re-rating window for export-focused midcaps within 6–12 months if capital flows resume. Losers include alternative low-cost Asian producers (Vietnam/Bangladesh) who lose some price advantage, and short-term US exporters to other markets if India shifts procurement; FX: INR likely to strengthen 3–7% on confirmed deal flow, pressuring INR-hedged dollar positions.

Risk assessment: The largest tail risk is a false/partial announcement — no joint text or narrow product scope — producing a sharp reversal (20%+ volatility in India ETFs/rupee inside 48–72 hours). Short-term (days) reaction = sentiment spike; medium (weeks–months) = capital inflows/FX moves; long-term (12–36 months) = structural supply-chain reallocation which requires capex and policy follow-through. Hidden dependencies include oil imports (defensive for fiscal), EU deal interactions and onshore tariff-lines; catalysts are a signed US-India tariff schedule, WTO notifications, and US export credit commitments within 30–90 days.

Trade implications: Tactical plays: buy India beta (INDA) and FX-hedged exposure to exporters; use 3–12 month horizons. Implement low-cost option structures to limit downside if the deal proves cosmetic. Rotate away from China-focused large-cap cyclicals if India becomes clearer alternative for Western MNC sourcing over 12–24 months.

Contrarian view: Consensus overweights the political certainty of the announcement; the market may underprice the time and capex needed for supply-chain shifts — meaningful share gains for India likely take 12–36 months, not weeks. Also, rupee appreciation could compress exporters' rupee-margin competitiveness (second-order risk). Historical parallel: 2019 US tariff détente produced a 6–9 month sentiment rally but limited structural trade reconfiguration until supply-chain investments were made.

Key Decisions for Investors

• Establish a 3% long position in INDA (iShares MSCI India ETF) within 2–6 weeks conditional on a joint US-India communiqué within 60 days; set tactical stop-loss at -8% and a 12-month target of +20% (take profits in tranches at +10% and +20%).
• Deploy a 1–2% notional long INR position via a 6‑month forward/NDF (or onshore INR swaps) targeting 5% appreciation vs USD; hard stop at -3% to protect against a headline reversal if no formal text appears within 30 days.
• Buy a 3‑month INDA call spread (buy 1x ~6% OTM call, sell 1x ~12% OTM call) sized to 1% portfolio risk-equivalent to capture a positive rerating while capping premium; roll or take profit if INDA rallies >12% pre-expiry.
• Trim 2–3% gross exposure to China-large cap ETF FXI and redeploy into India beta (INDA) and selective INR exposure over the next 3 months — reallocations to be reversed only if a formal US-India tariff schedule is not published within 90 days.